Register now

The SEA NSCLC Academy is a series of three educational webinars that aims to improve the management of non-small cell lung cancer (NSCLC) in Southeast Asia (SEA) and Hong Kong through keynote lectures and knowledge exchange.

The first two webinars included discussions on the importance of KRAS mutation in NSCLC and KRAS G12C testing in clinical practice. In this final webinar of the series, international and regional speakers will focus on the recent breakthroughs in the NSCLC treatment landscape, and how to translate these latest clinical advances to improve patient outcomes.

The SEA NSCLC Academy is a series of three educational webinars that aims to improve the management of non-small cell lung cancer (NSCLC) in Southeast Asia (SEA) and Hong Kong through keynote lectures and knowledge exchange.

The first two webinars included discussions on the importance of KRAS mutation in NSCLC and KRAS G12C testing in clinical practice. In this final webinar of the series, international and regional speakers will focus on the recent breakthroughs in the NSCLC treatment landscape, and how to translate these latest clinical advances to improve patient outcomes.
SC-HKG-AMG 510-00072
SC-MAL-AMG 510-00081
SC-THA-AMG 510-00042-0922

Dr Voon Pei Jye is the Head and Consultant Medical Oncologist, Department of Radiotherapy and Oncology, Hospital Umum Sarawak (Sarawak General Hospital). He obtained his MRCP (UK) and Master of Medicine (Internal Medicine) from National University of Singapore in 2007. Subsequently, he received his advanced specialist training in Medical Oncology from National University Hospital Singapore. He has completed his Phase 1 Drug Development clinical research fellowship at Princess Margaret Cancer Centre, University of Toronto, Canada. 

He is an active investigator for numerous cancer trials encompassing early phase through to late phase studies. He has keen interest in oncology development therapeutic, health related quality of life and health care delivery as well as cancer genetic and pharmacogenomic. Dr Voon has published in various peer reviewed journals. He is a recipient for Hold’em for Life Oncology Fellowship Award, University of Toronto. He has also won the Scholar Training Award from AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2021.